Need for More Research While current studies are promising, researchers agree that more research is needed
T 3 is three to five times more active than T 4
For urgent concerns, contact NHS 111 or your GP practice
The populations also differed: TRIUMPH-4 enrolled adults living with obesity and knee osteoarthritis over 68 weeks, while TRANSCEND-T2D-1 enrolled people living with type 2 diabetes over 40 weeks
During a presentation at ObesityWeek, Aronne presented data on nimacimab (Skye Bioscience), a once-weekly subcutaneous cannabinoid receptor 1 antibody that differs from the previously investigated agents
These findings open a new frontier in personalized neuroendocrine therapy, particularly relevant for postmenopausal women, who bear a disproportionate burden of AD and are often underrepresented in clinical trials